Medication info
Lipitor 5 mg (Atorvastatin Calcium Trihydrate)

Lipitor 5 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Trihydrate›5.425mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
Bottle - 30 tablets/bottle, PTP - 30 tablets/PTP [10 tablets/PTP packaging x 3]
Approval status
Active

MFDS item code 202400512 · Approved 2024.03.11 · Insurance code 643309480

Summary

Main use
Improvement of hyperlipidemia (hypercholesterolemia and mixed dyslipidemia)
Who uses it
Adults
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 5mg or 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered in a dose range of 5 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. As the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Older adults: Efficacy and safety in patients aged 70 years and older are generally similar to those in the usual adult patient population.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (hypercholesterolemia and mixed dyslipidemia)

  • Hyperlipidemia
  • primary hypercholesterolemia
  • dyslipidemia
  • elevated total cholesterol
  • LDL cholesterol
  • apo-B proteins
  • and triglyceride levels
View approved original text

This medication lowers elevated total cholesterol and LDL cholesterol, apo-B proteins, and triglyceride levels due to primary hypercholesterolemia and mixed dyslipidemia. Additionally, it helps raise HDL cholesterol levels, improving the lipid balance in the blood. It is more effective when used in conjunction with dietary adjustments and contributes to reducing the risk of cardiovascular diseases. This action is utilized to effectively manage hyperlipidemia.

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 5mg or 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered in a dose range of 5 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. As the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Older adults: Efficacy and safety in patients aged 70 years and older are generally similar to those in the usual adult patient population.

Precautions

If any abnormal muscle symptoms appear or muscle enzyme levels significantly increase, treatment should be discontinued. Especially if serious myopathy or rhabdomyolysis is suspected, treatment should be stopped immediately. Patients with severely impaired liver function, pregnant women, lactating women, and children under 10 years old should not use this medication. Caution is required for patients with a history of alcohol addiction or liver disease, as well as for those with a history of muscle-related diseases or elderly patients. If symptoms such as muscle pain, muscle weakness, or fatigue appear during treatment, notify a physician immediately. If symptoms indicative of liver dysfunction, such as nausea, vomiting, or malaise occur, discontinue use and seek medical attention. Women of childbearing age must use appropriate contraception while taking this medication, and if pregnancy is confirmed, the medication should be stopped immediately. This drug has many interactions with other medications, so inform the doctor or pharmacist about any other medications being taken. In particular, co-administration with certain antibiotics, antifungals, antivirals, grapefruit juice, etc., may increase blood concentration, raising the risk of side effects. Regular blood tests and liver function tests should be conducted to check for abnormalities during treatment. If muscle pain or weakness is severe or if muscle enzyme levels significantly rise, treatment should be stopped and a physician consulted. Children and elderly patients should be monitored more closely during treatment. There is no specific antidote for overdose; symptomatic treatment should be provided, and liver function and muscle enzyme levels should be tested. This medication should be kept out of the reach of children and stored in the original container to prevent misuse and degradation.

Side effects

  • Myopathy
  • rhabdomyolysis
  • constipation
  • diarrhea
  • nausea
  • vomiting
  • hypertension
  • hypotension
  • obstructive cholangitis
  • dehydration
Show 95 more
  • weakness
  • fatigue
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
  • loss of appetite
  • abdominal bloating
  • dyspepsia
  • nausea
  • abdominal pain
  • belching
  • pancreatitis
  • pharyngolaryngeal pain
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste disturbance
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myositis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • positive urinary leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • elevated cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • elevated potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • hyperlipidemia
  • facial flushing
  • increased non-protein nitrogen
  • hyperuricemia
  • gingival hypertrophy
  • hypothermia
  • sleep disorders
  • amnesia
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • cognitive impairment
  • myasthenia gravis
  • oculomotor weakness
  • elevated AST

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to keep it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

Bottle - 30 tablets/bottle, PTP - 30 tablets/PTP [10 tablets/PTP packaging x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.